What is the latest status of the project “TerraPower Isotopes Radiopharma Manufacturing Facility”?

The status recorded for “TerraPower Isotopes Radiopharma Manufacturing Facility” is planned.

What is the budget and commercial profile for the project “TerraPower Isotopes Radiopharma Manufacturing Facility”?

Taiyo normalizes the budget of “TerraPower Isotopes Radiopharma Manufacturing Facility” to USD 450000000.

Where can I verify the source and access all details for “TerraPower Isotopes Radiopharma Manufacturing Facility”?

This Taiyo project page references Radiology Business along with the original URL (https://radiologybusiness.com/topics/medical-imaging/nuclear-medicine/bill-gates-backed-nuclear-medicine-company-investing-450m-build-new-radiopharma-facility). Taiyo standardizes official data into a consistent, searchable project profile.

TerraPower Isotopes Radiopharma Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Philadelphia, Pennsylvania, United States

Source: Radiology Business

Project

Planned

TerraPower Isotopes, backed by Bill Gates, is investing $450 million to build a new radiopharmaceutical manufacturing facility in the Bellwether District of Philadelphia, Pennsylvania. The 250,000-square-foot build-to-suit facility will produce actinium-225, a rare radioactive isotope used in targeted cancer therapy. The expansion aims to increase production 20-fold and establish the company as a

Status: Prospective
Sector: Manufacturing (Industrial), Nuclear, Hospital
Location: Philadelphia, Pennsylvania, United States of America
Updated: 22 Jul 2026
Source: Radiology Business

ConstructChat

Ask ConstructChat about TerraPower Isotopes Radiopharma Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “TerraPower Isotopes Radiopharma Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Philadelphia, Pennsylvania, United States. Taiyo aggregates data on it from Radiology Business.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	TerraPower Isotopes, backed by Bill Gates, is investing $450 million to build a new radiopharmaceutical manufacturing facility in the Bellwether District of Philadelphia, Pennsylvania. The 250,000-square-foot build-to-suit facility will produce actinium-225, a rare radioactive isotope used in targeted cancer therapy. The expansion aims to increase production 20-fold and establish the company as a premier global distributor of actinium-225. The project is expected to create about 225 full-time jobs and 500 temporary construction jobs, with isotope production launching in 2029.
Original sector	Healthcare
Budget

Location

Country	United States of America (USA)
State	Pennsylvania
City	Philadelphia

Source

Source	Radiology Business
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial), Nuclear, Hospital
Article published date	2026-03-22

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

TerraPower Isotopes Radiopharma Manufacturing Facility

Ask ConstructChat about TerraPower Isotopes Radiopharma Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States